Cyberonics Kicking Off Obesity Phase I, Depression Phase III Trials
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics will decide whether to proceed with U.S. pivotal trials of its NeuroCybernetic Prosthesis (NCP) vagus nerve stimulation system (VNS) for treatment of morbid obesity sometime in summer 2002.
You may also be interested in...
Inamed's Lap Band Poised To Squeeze Out U.S. Morbid Obesity Market In 2000
Introduction of the Lap Band adjustable gastric banding system could increase Inamed obesity product sales up to four-fold by 2002, Inamed President Ilan Reich told investors attending the Bear Stearns Healthcare Conference Sept. 17 in New York City.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.